Medical News: ECCO-ESMO: Combo Looks Good for Later Breast Cancer Tx - in Meeting Coverage, ECCO-ESMO from MedPage Today
Links shared publicly online about this topic.
- 0total visits
Medical News: ECCO-ESMO: Combo Looks Good for Later Breast Cancer Tx - in Meeting Coverage, ECCO-ESMO from MedPage Today
STOCKHOLM -- Adding the PARP inhibitor iniparib to gemcitabine (Gemzar) plus carboplatin (Paraplatin) may benefit triple-negative metastatic breast cancer patients when used as second- or third-line t
View full resource at medpagetoday.com
Tags: Cancer, Cancer Medication, Breast Cancer, Metastatic Breast Cancer, Women's Health, Gemzar, News, Medical
Most Recently Shared on September 29, 2011 at 9:53 pm By:
ECCO-ESMO: Combo Looks Good for Later Breast Cancer Tx (CME/CE) http://t.co/oB0QBkVq
Advertisement
